Inflammatory profiles define phenotypes with clinical relevance in acute type A aortic dissection
- PMID: 37713048
- DOI: 10.1007/s12265-023-10436-z
Inflammatory profiles define phenotypes with clinical relevance in acute type A aortic dissection
Abstract
Association of distinct inflammatory profiles with short-term mortality is little known in type A aortic dissection (TAAD). Latent class analysis was used to identify distinct inflammatory profiles based on leukocyte, neutrophils, monocyte, lymphocytes, platelet, fibrinogen, D-dimer, neutrophils-lymphocyte ratio, platelet-lymphocyte ratio, and lymphocyte-monocyte ratio. We identified 193 patients with median age of 56 (IQR 47-63) years and 146 males. Patients were divided as hyper-inflammatory profiles (84 [43.5%]) and hypo-inflammatory profiles (109 [56.5%]). Although baseline characteristics were not different, hyper-inflammatory patients had higher 6-month mortality (20 [23.8%] vs. 11 [10.1%]; P = 0.014) and 30-day mortality (18 [21.4%] vs. 9 [8.3%], P = 0.009) than hypo-inflammatory patients. After adjustment for potential confounders, hyper-inflammatory profiles remain associated with higher risk of 6-month mortality than hypo-inflammatory profiles (adjusted OR 2.427 [95%CI 1.154, 5.105], P = 0.019). Assessment of preoperative inflammatory profiles adds clarity regarding the extent of inflammatory response to TAAD aetiopathologies, highlighting individual anti-inflammatory pharmacotherapy for TAAD. ClinicalTrials.gov Identifier: NCT04398992.
Keywords: Inflammatory response; Latent class analysis; Mortality; Type A aortic dissection.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Impact of Lymphocyte-Related Blood Parameters on Short- and Long-Term Outcomes of Patients Undergoing Thoracic Endovascular Aortic Repair.Angiology. 2021 Nov;72(10):953-960. doi: 10.1177/00033197211012514. Epub 2021 May 6. Angiology. 2021. PMID: 33955277
-
Admission D-dimer to lymphocyte counts ratio as a novel biomarker for predicting the in-hospital mortality in patients with acute aortic dissection.BMC Cardiovasc Disord. 2023 Feb 5;23(1):69. doi: 10.1186/s12872-023-03098-x. BMC Cardiovasc Disord. 2023. PMID: 36740681 Free PMC article.
-
Relationship of admission neutrophil-to-lymphocyte ratio with in-hospital mortality in patients with acute type I aortic dissection.Turk J Med Sci. 2014;44(2):186-92. Turk J Med Sci. 2014. PMID: 25536722
-
Research Progress on B Cells and Thoracic Aortic Aneurysm/Dissection.Ann Vasc Surg. 2022 May;82:377-382. doi: 10.1016/j.avsg.2021.11.018. Epub 2021 Dec 18. Ann Vasc Surg. 2022. PMID: 34933111 Review.
-
Intentional Targeted False Lumen Occlusion after Aortic Dissection: A Systematic Review of the Literature.Ann Vasc Surg. 2019 Apr;56:317-329. doi: 10.1016/j.avsg.2018.08.086. Epub 2018 Nov 26. Ann Vasc Surg. 2019. PMID: 30496905
Cited by
-
Establishment of a nomogram model based on immune-related genes using machine learning for aortic dissection diagnosis and immunomodulation assessment.Int J Med Sci. 2025 Jan 21;22(4):873-886. doi: 10.7150/ijms.100572. eCollection 2025. Int J Med Sci. 2025. PMID: 39991758 Free PMC article.
-
Aortic atherosclerosis evaluation using deep learning based on non-contrast CT: A retrospective multi-center study.iScience. 2025 Jul 12;28(8):113100. doi: 10.1016/j.isci.2025.113100. eCollection 2025 Aug 15. iScience. 2025. PMID: 40799398 Free PMC article.
-
Protective effect of ulinastatin against negative inflammatory response and organ dysfunction in acute aortic dissection surgery: The PANDA trial.Cell Rep Med. 2025 Jan 21;6(1):101888. doi: 10.1016/j.xcrm.2024.101888. Cell Rep Med. 2025. PMID: 39842406 Free PMC article. Clinical Trial.
-
Inflammatory Trajectory and Anti-Inflammatory Pharmacotherapy in Frozen Elephant Trunk-Treated Acute Type I Aortic Dissection.J Soc Cardiovasc Angiogr Interv. 2024 Apr 5;3(7):101935. doi: 10.1016/j.jscai.2024.101935. eCollection 2024 Jul. J Soc Cardiovasc Angiogr Interv. 2024. PMID: 39132007 Free PMC article.
-
Biomarkers to predict the outcomes of surgical intervention for aortic dissection.J Cardiothorac Surg. 2025 Feb 5;20(1):116. doi: 10.1186/s13019-024-03226-4. J Cardiothorac Surg. 2025. PMID: 39910669 Free PMC article. Review.
References
-
- Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, et al. ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(41):2873–926. - DOI - PubMed
-
- Liu H, Li HY, Han Lu, Zhang YY, Wu Y, Hong L, et al. Inflammatory risk stratification individualizes anti-inflammatory pharmacotherapy for acute type A aortic dissection. Innovation. 2023;4(4):100. https://doi.org/10.1016/j.xinn.2023.100448 . - DOI
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical